Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07206095

Integrative Diagnosis for SCD and Other RADs

Sponsor: Hospital Universitari Vall d'Hebron Research Institute

View on ClinicalTrials.gov

Summary

INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and genetic characterization through combining new generation methodologies.

Official title: Integrative Diagnosis of Sickle Cell Disease (SCD) and Other Rare Anemia Disorders (RADs) for Personalized Medicine

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2020-11-13

Completion Date

2028-05

Last Updated

2025-10-03

Healthy Volunteers

No

Interventions

GENETIC

Analysis of genetic modifiers

Genetic modifiers for rare anemia disorders will be analyzed through massive sequencing.

DIAGNOSTIC_TEST

Disease phenotyping

Peripheral blood samples will be used for conventional phenotyping characterization including among others: RBCs morphology, fragility osmotic test, hemoglobin fraction and quantification, hemoglobin stability test, EMA binding test, RBC enzymes quantification assay, RBC rheological properties through Lorrca Maxsis Osmoscan/Oxygescan (Lorrca®)

Locations (9)

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, Spain

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona, Spain

Hospital Sant Joan de Déu

Esplugues de Llobregat, Barcelona, Spain

Hospital General de Granollers

Granollers, Barcelona, Spain

Consorci Sanitari del Maresme - Hospital de Mataró

Mataró, Barcelona, Spain

Parc Taulí Hospital Universitari

Sabadell, Barcelona, Spain

Hospital Universitari Mútua de Terrassa

Terrassa, Barcelona, Spain

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain

Hospital Universitari Arnau de Vilanova

Lleida, Lleida, Spain